Pharmaniaga Q2 net profit jumps to RM12.49m on interest savings, stronger sales

In a filing with Bursa Malaysia, the healthcare company said the higher net profit was attributable to RM7 million in realised interest savings following the partial repayment of borrowings, supported by effective inventory management.

Revenue also increased to RM1.04 billion for the quarter under review from RM926.86 million in the corresponding quarter in FY2025, driven by higher order volumes from government hospitals under the Approved Products Purchase List (APPL) and increased sales from the private segment.

…